Deutsche Bank Reiterates Hold, $12 PT On Targacept

In a note out today, Deutsche Bank reiterated a hold rating and $12 price target on biotech firm Targacept TRGT. The price target implies roughly 50% upside from current levels. Deutsche Bank said downside in the stock is buffered by the company's $7 per share in cash.